Publikation
Current status and future outlooks on therapeutic drug monitoring of fluorouracil.
Wissenschaftlicher Artikel/Review - 24.01.2022
Schmulenson Eduard, Zimmermann Nigina, Mikus Gerd, Jörger Markus, Jaehde Ulrich
Bereiche
PubMed
DOI
Kontakt
Zitation
Schmulenson E, Zimmermann N, Mikus G, Jörger M, Jaehde U. Current status and future outlooks on therapeutic drug monitoring of fluorouracil. Expert Opin Drug Metab Toxicol 2022; 17:1407-1422.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Expert Opin Drug Metab Toxicol 2022; 17
Veröffentlichungsdatum
24.01.2022
eISSN (Online)
1744-7607
Seiten
1407-1422
Kurzbeschreibung/Zielsetzung
Therapeutic drug monitoring (TDM) of the anticancer drug fluorouracil (5FU) as a method to support dose adjustments has been researched and discussed extensively. Despite manifold evidence of the advantages of 5FU-TDM, traditional body surface area (BSA)-guided dosing is still widely applied.